Francesca Barone

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

CADL

Current role

Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Candel Therapeutics, Inc. (CADL)	M.D., Chief Scientific Officer	$483,312	—	—	$857,797	$206,427	$14,000	$1,561,536
2024	Candel Therapeutics, Inc. (CADL)	M.D., Chief Scientific Officer	$443,303	—	—	—	$269,119	$13,800	$726,222
2023	Candel Therapeutics, Inc. (CADL)	M.D., Chief Scientific Officer	$413,005	—	$110,534	$89,577	$80,560	$13,200	$706,876
2022	Candel Therapeutics, Inc. (CADL)	M.D., Chief Scientific Officer	$362,192	—	$155,400	$233,988	$144,522	$12,200	$908,302
2021	Candel Therapeutics, Inc. (CADL)	M.D., Ph.D.Chief Scientific Officer	$259,728	—	—	—	$101,500	$3,569	$364,797

No earnings-call appearances or filed executive changes recorded yet.